Maven Securities’s Biohaven BHVN Stock Holding History

Maven Securities’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-251,200	Closed	-$3.49M	–	923
2022 Q4	$3.49M	Buy	+251,200	New	+$3.55M	0.08%	152

Other funds holding BHVN

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Maven Securities's BHVN Position: Q4 2023 in Review

Maven Securities sold out of Biohaven (BHVN) in Q4 2023, closing a stake of 225,000 shares — an estimated $5.85M sold.

Maven Securities first reported a position in BHVN in Q4 2022 and held it in 4 quarters. The position peaked at $7.55M in Q4 2022. 218 funds tracked by Wall St. Rank hold BHVN as of Q4 2023.

Maven Securities reported no remaining Biohaven position as of Q4 2023 after selling out during the quarter.
Maven Securities sold 225,000 Biohaven shares in Q4 2023, an estimated $5.85M.
Maven Securities first reported a position in Biohaven in Q4 2022 and held it in 4 quarters.
Maven Securities's Biohaven position peaked at $7.55M in Q4 2022.
218 funds tracked by Wall St. Rank held Biohaven as of Q4 2023.

Based on Maven Securities's 13F filing for Q4 2023, filed 12 Feb 2024.